Thrivent Financial For Lutherans Dexcom Inc Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Dexcom Inc stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 314,102 shares of DXCM stock, worth $23.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

314,102

Previous 217,828 44.2%

Holding current value

$23.8 Million

Previous $24.7 Million 14.73%

% of portfolio

0.04%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$64.0 - $116.06 $6.16 Million - $11.2 Million	96,274 Added 44.2%	314,102 $21.1 Million
Q2 2024 Aug 13, 2024	SELL	$110.31 - $140.45 $1.24 Million - $1.57 Million	-11,205 Reduced 4.89%	217,828 $24.7 Million
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $1.75 Million - $2.15 Million	-15,352 Reduced 6.28%	229,033 $31.8 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $919,468 - $1.51 Million	12,180 Added 5.25%	244,385 $30.3 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $58.8 Million - $94.2 Million	-682,742 Reduced 74.62%	232,205 $21.7 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $7.68 Million - $8.95 Million	68,315 Added 8.07%	914,947 $118 Million
Q1 2023 May 17, 2023	BUY	$104.0 - $122.92 $65.3 Million - $77.2 Million	628,201 Added 287.6%	846,632 $98.4 Million
Q4 2022 Feb 08, 2023	SELL	$84.98 - $122.67 $806,970 - $1.16 Million	-9,496 Reduced 4.17%	218,431 $24.7 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $122,999 - $151,723	1,611 Added 0.71%	227,927 $18.4 Million
Q2 2022 Aug 16, 2022	BUY	$67.99 - $132.89 $11.5 Million - $22.4 Million	168,615 Added 292.22%	226,316 $16.9 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $14.6 Million - $20.2 Million	-154,874 Reduced 72.86%	57,701 $29.5 Million
Q4 2021 Feb 16, 2022	SELL	$129.87 - $162.82 $4.39 Million - $5.5 Million	-33,768 Reduced 13.71%	212,575 $114 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $6.59 Million - $8.84 Million	-61,744 Reduced 20.04%	246,343 $135 Million
Q2 2021 Aug 19, 2021	BUY	$80.99 - $107.93 $1.29 Million - $1.72 Million	15,963 Added 5.46%	308,087 $132 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $167,884 - $207,385	-1,980 Reduced 0.67%	292,124 $105 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $16.5 Million - $22.2 Million	212,174 Added 258.97%	294,104 $109 Million
Q3 2020 Nov 10, 2020	SELL	$95.51 - $112.95 $289,968 - $342,916	-3,036 Reduced 3.57%	81,930 $33.8 Million
Q2 2020 Aug 12, 2020	SELL	$62.68 - $105.34 $1.22 Million - $2.06 Million	-19,535 Reduced 18.69%	84,966 $34.4 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $1.25 Million - $1.98 Million	26,230 Added 33.51%	104,501 $28.1 Million
Q4 2019 Feb 13, 2020	BUY	$36.62 - $57.29 $313,027 - $489,714	8,548 Added 12.26%	78,271 $17.1 Million
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $56,030 - $69,072	1,577 Added 2.31%	69,723 $10.4 Million
Q2 2019 Aug 13, 2019	SELL	$27.84 - $38.92 $1.58 Million - $2.21 Million	-56,784 Reduced 45.45%	68,146 $10.2 Million
Q1 2019 May 14, 2019	SELL	$28.07 - $38.18 $490,102 - $666,622	-17,460 Reduced 12.26%	124,930 $14.9 Million
Q3 2018 Nov 15, 2018	SELL	$23.35 - $36.72 $118,618 - $186,537	-5,080 Reduced 3.44%	142,390 $20.4 Million
Q1 2018 May 08, 2018	SELL	$13.06 - $18.54 $164,817 - $233,974	-12,620 Reduced 7.88%	147,470 $10.9 Million
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $88,626 - $122,578	7,970 Added 5.24%	160,090 $9.19 Million
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $1.73 Million - $2.89 Million	152,120	152,120 $7.44 Million

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Dexcom Inc Transaction History